Publicacións en colaboración con investigadores/as de Institut d'Investigació Biomèdica Girona (3)

2022

  1. Olfactomedin 2 deficiency protects against diet-induced obesity

    Metabolism: Clinical and Experimental, Vol. 129

2020

  1. Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)

    Lung Cancer, Vol. 150, pp. 62-69

  2. Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis

    Molecular Metabolism, Vol. 31, pp. 67-84